Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

The right to withdraw from controlled human infection studies

Justifications and avoidance

Bibliographic Data

ID21504100
AuthorsHolly Fernandez Lynch (0000-0001-7813-9879, Department of Medical Ethics and Health Policy Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania, corresponding author)
Year2020
Volume34
Issue8
Pages833-848
Publication date2020-10-01
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueBioethics (JOURNAL)
Journal identifiersISSN: 0269-9702 • E-ISSN: 1467-8519
PublisherWiley (PUBLISHER • GB)
DOI10.1111/bioe.12704
PMID31976568
OpenAlexW3001799194
LanguageEN
Citations received2

The right to withdraw from research without penalty is well established around the world. However, it has been challenged in some corners of bioethics based on concerns about various harms—to participants, to scientific integrity, and to research bystanders—that may stem from withdrawal. These concerns have become particularly salient in emerging debates about the ethics of controlled human infection (CHI) studies in which participants are intentionally infected with pathogens, often in inpatient settings with extensive follow‐up. In this article, I provide support for preserving the right to withdraw from research without penalty and demonstrate that it is also typically justified in the specific context of CHI studies. The right is well aligned with individual freedoms outside the research setting, where autonomous individuals are permitted to engage in behaviors that will foreseeably cause them harm; where they cannot be compelled to satisfy contracts for their services, nor penalized for failure to do so; and where their behavior is not constrained by public health authorities except in extreme circumstances. These freedoms are supported by U.S. law, as well as by ethical analysis that is more globally relevant. The problems associated with the right to withdraw, however, remain. The best approach to addressing them is not to restrict the right but rather to avoid initiating research when withdrawal would be especially problematic. If research proceeds, steps can still be taken to minimize participant withdrawal without infringing the right. Investigators can avoid participant surprise through informed consent focused on a study’s most burdensome aspects and promote study completion through financial incentives. Should participants nonetheless seek to withdraw, investigators may attempt to persuade them not to do so by encouraging consideration of the range of potential harms that may result. Researchers conducting CHI studies and other research from which withdrawal might be especially problematic should prepare for the possibility of participant withdrawal, respect participant requests to withdraw without penalty, and incorporate various measures to avoid such requests

Bioethics · Harm · Human rights · Informed consent · Law and economics · Political science · Psychiatry · Research ethics · Right to health · Sociology · Surprise · Biomedical Ethics and Regulation · Ethics in Clinical Research · Ethics in medical practice · Law · Medicine · Psychology · Social Psychology

  • Back to WHAT? The role of research ethics in pandemic times

    Open Access•Jan Helge Solbakk, Heidi Beate Bentzen et al.•Medicine Health Care and Philosophy•2021

  • Human infection challenge studies in endemic settings and/or low-income and middle-income countries

    Open Access•Euzebiusz Jamrozik, Michael J Selgelid•Journal of Medical Ethics•2020

Unique citing works2
Citations per year0.33
Citation span2020 - 2021 (2)
Citation velocityhistorical
Highly citedNo
Citation typesNeutral: 2

Tools

Open DOISci-Hub
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae